There’s one fungus that sounds alarm bells in America: yeast infections. Candida auris are increasing more than normal. From 2020 to 2021, cases in the US will double, a study published in a scientific journal warned earlier this week. This is an “extraordinary and very serious development”, says Diego Correa, but according to the professor of international health, the “greatest concern” is the resistance of this fungus to treatment.
oh Candida auris This type of infection is highly resistant to the drugs commonly administered to treat it – the echinocandins – and, therefore, the fungus is considered a Superbuck, says a researcher from the Institute of Health and Tropical Medicine at the Universidad Nova de Lisboa. Antimicrobial resistance “makes infections more difficult to treat, with a higher risk of infection, a higher risk of severe illness and death,” he explains.
Compared to 2019 and 2020, cases in the United States are expected to triple in 2021, according to a study in the “Annals of Internal Medicine” that analyzed data from the Centers for Disease Control and Prevention (CDC). Officials at local and state level. Specifically, through infection Candida auris Growing from 44% in 2019 to 95% in 2021.
This fungus is not new: it was reported in the United States in 2016, and was first detected in Japan in 2009 in a woman’s ear. Since then, the Candida auris Spread in some countries of the world including the European continent. In Portugal, the superorganism caused some concern in 2019, but no cases have been confirmed in the country (at least so far).
Exclusive article for subscribers
Subscribe now for €1.63 per week.